Show simple item record

Clinical Pharmacology and Pharmacy of Antimicrobial Agents

dc.contributor.editorKovács, Dóra
dc.date.accessioned2023-11-30T20:56:13Z
dc.date.available2023-11-30T20:56:13Z
dc.date.issued2023
dc.identifierONIX_20231130_9783036591094_275
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/128823
dc.description.abstractIn this Special Issue, our aim was to collect studies on clinical pharmacology and pharmacy of antimicrobial agents from both human and veterinary medicine as the complex problem of AMR requires actions taken within the One Health approach that involve both fields. Studies covered here are about new or optimized usage of already authorized antimicrobials, as well as discoveries about new agents, new combinations of drugs, and drug repositioning. Pharmacodynamic, pharmacokinetic, and toxicological aspects of individual and combinational drug use are areas covered in this Special Issue.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacologyen_US
dc.subject.otherantibiotic combination
dc.subject.otherminimum inhibitory concentration
dc.subject.otherMonte Carlo
dc.subject.othersynergistic effect
dc.subject.otherantibiotics
dc.subject.othercombination therapy
dc.subject.othermulti-drug resistant infection
dc.subject.othermeta-analysis
dc.subject.otherpan-genome
dc.subject.otherCampylobacter ureolyticus
dc.subject.otherUDP-3-O-acyl-N-acetylglucosamine deacetylase
dc.subject.otherLpxC
dc.subject.othercampylobacteriosis
dc.subject.otherself-medication
dc.subject.otherstudents
dc.subject.otherhabits
dc.subject.othercystic fibrosis
dc.subject.otherP. aeruginosa
dc.subject.othertransporters
dc.subject.otherEscherichia coli
dc.subject.othersuture
dc.subject.otherantimicrobial
dc.subject.otherpharmacodynamics
dc.subject.othertriclosan
dc.subject.othersurgical site infection
dc.subject.othertime-kill
dc.subject.othercontact killing
dc.subject.othertranslational modelling
dc.subject.otherantifungals
dc.subject.otheradverse drug reaction (ADR)
dc.subject.otherdrug-drug interaction (DDI)
dc.subject.otherpolypharmacy
dc.subject.othermultimorbidity
dc.subject.otherintensive care patients
dc.subject.othertraumatology
dc.subject.otherelderly patients
dc.subject.otherorgan failure
dc.subject.othermulti-organ failure
dc.subject.otherdrug safety
dc.subject.otherpatient safety
dc.subject.othernonlinear mixed-effects modeling
dc.subject.otherglomerular filtration rate
dc.subject.otherdosing regimen
dc.subject.otheroxacillin
dc.subject.otherMonte Carlo simulations
dc.subject.otheradsorption
dc.subject.otherdesorption
dc.subject.otherdoxycycline
dc.subject.otherpH dependence
dc.subject.othersmall ruminant feed
dc.subject.otherheterocyclic compounds
dc.subject.otherphenolic compounds
dc.subject.otherpyran
dc.subject.otherfood microbiology
dc.subject.othermicrobial pathogen
dc.subject.otherserum/plasma concentrations
dc.subject.otherinterstitial concentrations
dc.subject.othertissue concentrations
dc.subject.otherpharmacokinetics
dc.subject.othermacrolide antibiotics
dc.titleClinical Pharmacology and Pharmacy of Antimicrobial Agents
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-9108-7
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036591094
oapen.relation.isbn9783036591087
oapen.pages196
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/